CD47 and cancer: The knockdown efficiencyof CD47 protein, changes of CRT levels, and phagocytosis of tumorcells by macrophages were investigated and compared among the nanocarrierswith different dimensions and possibly different delivery routes.With different carriers and delivery strategies, different levelsof CRT and CD47 expression levels could be achieved using the sametypes of cancer cell systems.